dc.contributor.author | Cui, Guanglin | |
dc.contributor.author | Fan, Qingbo | |
dc.contributor.author | Li, Zhenfeng | |
dc.contributor.author | Goll, Rasmus | |
dc.contributor.author | Florholmen, Jon | |
dc.date.accessioned | 2021-09-28T07:50:42Z | |
dc.date.available | 2021-09-28T07:50:42Z | |
dc.date.created | 2021-05-06T13:53:52Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Cui, G., Fan, Q., Li, Z., Goll, R. & Florholmen, J. (2021). Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. EBioMedicine, 66: 103329. doi: | en_US |
dc.identifier.issn | 2352-3964 | |
dc.identifier.uri | https://hdl.handle.net/11250/2783939 | |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.no | * |
dc.title | Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease : Current and novel biomarkers | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | © 2021 The Author(s) | en_US |
dc.subject.nsi | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Infeksjonsmedisin: 776 | en_US |
dc.subject.nsi | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gasteroenterologi: 773 | en_US |
dc.source.pagenumber | 9 | en_US |
dc.source.volume | 66 | en_US |
dc.source.journal | EBioMedicine | en_US |
dc.identifier.doi | 10.1016/j.ebiom.2021.103329 | |
dc.identifier.cristin | 1908545 | |
dc.relation.project | Northern Norway Regional Health Authority: SFP-44-04 | en_US |
dc.source.articlenumber | 103329 | en_US |